drugset
drugset / Trial / NCT03390465

Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

NCT03390465 ↗

Phase 1 Completed 36 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the Drug interaction and safety of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy Male volunteers.

Timeline

Start
2017-12-15
Primary completion
2018-01-16
Completion
2018-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fimasartan/Amlodipine Unknown — —
Subject Hydrochlorothiazide Unknown — —

Indications

No indication recorded.